NCT00144066View on ClinicalTrials.gov

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

January 31, 2003

Conditions
Lung Cancer
Interventions
DRUG

platinum-based chemotherapy alone (up to six cycles)

DRUG

platinum-based chemotherapy followed by maintenance therapy with gefitinib

All Listed Sponsors
lead

West Japan Thoracic Oncology Group

OTHER

NCT00144066 - A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter